Literature DB >> 10858344

Rapid discriminatory detection of genes coding for SHV beta-lactamases by ligase chain reaction.

J Kim1, H J Lee.   

Abstract

Ligase chain reaction (LCR) is a recently developed technique that employs a thermostable ligase and allows for the discrimination of DNA sequences differing in only a single base pair. The method has been adapted and applied to differentiation of bla(SHV) genes. We have developed an LCR typing method to characterize point mutations in genes for SHV-derived extended-spectrum beta-lactamases with four different sets of biotinylated LCR primers. To evaluate the applicability of the current technique, we tested seven Escherichia coli strains producing SHV-1, SHV-2, SHV-2a, SHV-3, SHV-4, SHV-5, and SHV-12. With the LCR typing, seven SHV genes can be distinguished according to their incorporating point mutations. In an attempt to characterize SHV beta-lactamases by LCR typing in clinical isolates, 46 strains carrying bla(SHV) genes (32 Klebsiella pneumoniae, 10 Enterobacter cloacae, and 4 E. coli) were subjected to antibiotic susceptibility testing, isoelectric focusing, and LCR typing. LCR typing allowed the characterization of beta-lactamases, and genotypes obtained by LCR typing were in accordance with phenotypes such as antibiotic resistance profile and pI value of beta-lactamase. Therefore, we concluded that LCR typing may permit defining the SHV families with simplicity and reliability and can be applied to the detailed characterization and molecular epidemiology of SHV-type beta-lactamases.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10858344      PMCID: PMC89975          DOI: 10.1128/AAC.44.7.1860-1864.2000

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  28 in total

1.  Cloning of SHV-2, OHIO-1, and OXA-6 beta-lactamases and cloning and sequencing of SHV-1 beta-lactamase.

Authors:  J Mercier; R C Levesque
Journal:  Antimicrob Agents Chemother       Date:  1990-08       Impact factor: 5.191

2.  Development of "oligotyping" for characterization and molecular epidemiology of TEM beta-lactamases in members of the family Enterobacteriaceae.

Authors:  C Mabilat; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1990-11       Impact factor: 5.191

3.  Nucleotide sequence and phylogeny of SHV-2 beta-lactamase.

Authors:  A Huletsky; F Couture; R C Levesque
Journal:  Antimicrob Agents Chemother       Date:  1990-09       Impact factor: 5.191

Review 4.  More extended-spectrum beta-lactamases.

Authors:  G A Jacoby; A A Medeiros
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

Review 5.  TEM- and SHV-derived extended-spectrum beta-lactamases: relationship between selection, structure and function.

Authors:  S K Du Bois; M S Marriott; S G Amyes
Journal:  J Antimicrob Chemother       Date:  1995-01       Impact factor: 5.790

6.  SHV-7, a novel cefotaxime-hydrolyzing beta-lactamase, identified in Escherichia coli isolates from hospitalized nursing home patients.

Authors:  P A Bradford; C Urban; A Jaiswal; N Mariano; B A Rasmussen; S J Projan; J J Rahal; K Bush
Journal:  Antimicrob Agents Chemother       Date:  1995-04       Impact factor: 5.191

7.  Molecular characterisation by PCR-restriction fragment length polymorphism of TEM beta-lactamases.

Authors:  G Arlet; G Brami; D Décrè; A Flippo; O Gaillot; P H Lagrange; A Philippon
Journal:  FEMS Microbiol Lett       Date:  1995-12-15       Impact factor: 2.742

Review 8.  Genetics of extended-spectrum beta-lactamases.

Authors:  G A Jacoby
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994       Impact factor: 3.267

Review 9.  Extended-spectrum plasmid-mediated beta-lactamases.

Authors:  D Sirot
Journal:  J Antimicrob Chemother       Date:  1995-07       Impact factor: 5.790

10.  Dissemination of cephalosporin-resistant Serratia marcescens strains producing a plasmidic SHV type beta-lactamase in Greek hospitals.

Authors:  D Gianneli; E Tzelepi; L S Tzouvelekis; A F Mentis; C Nikolopoulou
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-09       Impact factor: 3.267

View more
  13 in total

1.  Isolation of an SHV-12 beta-lactamase-producing Escherichia coli strain from a dog with recurrent urinary tract infections.

Authors:  T Teshager; L Domínguez; M A Moreno; Y Saénz; C Torres; S Cardeñosa
Journal:  Antimicrob Agents Chemother       Date:  2000-12       Impact factor: 5.191

Review 2.  Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat.

Authors:  P A Bradford
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

3.  Real-time PCR and melting curve analysis for reliable and rapid detection of SHV extended-spectrum beta-lactamases.

Authors:  C C Randegger; H Hächler
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

4.  Discrimination of SHV beta-lactamase genes by restriction site insertion-PCR.

Authors:  A Chanawong; F H M'Zali; J Heritage; A Lulitanond; P M Hawkey
Journal:  Antimicrob Agents Chemother       Date:  2001-07       Impact factor: 5.191

5.  High prevalence of extended-spectrum beta-lactamase-producing strains among blood isolates of Enterobacter spp. collected in a tertiary hospital during an 8-year period and their antimicrobial susceptibility patterns.

Authors:  Hyunjoo Pai; Jung Yun Hong; Jeong-Hum Byeon; Yun-Kyung Kim; Hoan-Jong Lee
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

6.  Rapid detection and sequence-specific differentiation of extended-spectrum beta-lactamase GES-2 from Pseudomonas aeruginosa by use of a real-time PCR assay.

Authors:  Gerhard F Weldhagen
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

7.  Development of a multiplex PCR and SHV melting-curve mutation detection system for detection of some SHV and CTX-M beta-lactamases of Escherichia coli, Klebsiella pneumoniae, and Enterobacter cloacae in Taiwan.

Authors:  Ju-Hsin Chia; Chishih Chu; Lin-Hui Su; Cheng-Hsun Chiu; An-Jing Kuo; Chien-Feng Sun; Tsu-Lan Wu
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

8.  Bloodstream infections by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in children: epidemiology and clinical outcome.

Authors:  Yun-Kyung Kim; Hyunjoo Pai; Hoan-Jong Lee; Su-Eun Park; Eun-Hwa Choi; Jungmin Kim; Je-Hak Kim; Eui-Chong Kim
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

9.  Identification and minisequencing-based discrimination of SHV beta-lactamases in nosocomial infection-associated Klebsiella pneumoniae in Brisbane, Australia.

Authors:  Christopher Howard; Angela van Daal; Gregory Kelly; Jacqueline Schooneveldt; Graeme Nimmo; Philip M Giffard
Journal:  Antimicrob Agents Chemother       Date:  2002-03       Impact factor: 5.191

10.  Sequence-selective recognition of extended-spectrum beta-lactamase GES-2 by a competitive, peptide nucleic acid-based multiplex PCR assay.

Authors:  Gerhard F Weldhagen
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.